Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Francesco Menzella and Gianenrico Senna.
Francesco Menzella
Connection Strength
0.473
Gianenrico Senna
  1. Targeting eosinophils: severe asthma and beyond. Drugs Context. 2019; 8:212587.
    View in: PubMed
    Score: 0.208
  2. Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity. Respir Med. 2021 01; 176:106261.
    View in: PubMed
    Score: 0.057
  3. COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey. Allergy. 2021 03; 76(3):871-874.
    View in: PubMed
    Score: 0.056
  4. Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation. Allergy. 2019 12; 74(12):2539-2541.
    View in: PubMed
    Score: 0.052
  5. Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life. Pulm Pharmacol Ther. 2019 02; 54:87-89.
    View in: PubMed
    Score: 0.050
  6. The Severe Asthma Network in Italy: Findings and Perspectives. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1462-1468.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.